Immune Therapeutics, Inc. 5
5 · Immune Therapeutics, Inc. · Filed Mar 30, 2016
Insider Transaction Report
Form 5
Griffin Noreen
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Other
COMMON STOCK
2015-09-01+2,000,000→ 4,317,710 total(indirect: By Trust) - Other
COMMON STOCK
2015-12-31−2,000,000→ 4,317,710 total(indirect: By Trust) - Other
COMMON STOCK
2015-09-01+1,000,000→ 4,317,710 total - Other
COMMON STOCK
2015-09-17+1,300,000→ 4,317,710 total(indirect: By Trust) - Other
COMMON STOCK
2015-12-04$50000.00/sh−1,000,000$50,000,000,000→ 4,317,710 total - Other
COMMON STOCK
2015-12-31−1,300,000→ 4,317,710 total(indirect: By Trust)
Footnotes (5)
- [F1]The shares include 2,685,000 held by the Griffin Family Trust, an irrevocable trust for the benefit of the reporting person's children and grandchildren; 704,009 held by Griffin Enterprises Group, LLC which is 50% owbned by the reporting person and 50% owned and manged by Robert Wilson, the reporting person's son; and 928,701 held by Noreen Griffin directly.
- [F2]These shares were not previously reported because the were issued in error for past due salary and subsequently cancelled. The issuance and subsequent cancellation should have been reported on Form 4.
- [F3]The shares are held by the Griffin Family Trust, an irrevocable trust for the benefit of the reporting person's children and grandchildren. The reporting person's cousin is the trustee of the trust.
- [F4]These shares were not previously reported because the were issued in error for a contract extension and subsequently cancelled. The issuance and subsequent cancellation should have been reported on Form 4.
- [F5]The shares were inadvertently not previously reported. The shares were transferred in a private transaction to repay a personal loan.